Integrin antagonist 27

Overview

Integrin antagonist 27 (Compound 27) is a small molecule integrin αvβ3 antagonist with an affinity of 18 nM. Integrin antagonist 27 can be combined with Paclitaxel ( HY-B0015 ) to selectively target αvβ3 -positive metastatic cancer cells. Integrin antagonist 27 is used as an anticancer agent.

Application

Products | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Integrin

Product Information

• Catalog No.: HY-18668
• CAS No.: 593274-97-6
• Molecular Formula: C24H20N4O5
• Molecular Weight: 444.44
• Purity: 95.0%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.63 mM); Clear solution
• Availability: In-stock

Source

Original product source